论文部分内容阅读
灯盏花注射液是九十年代升级换代的活血化瘀型单味中成药静脉注射液,对治疗高粘滞血症有良好的药理作用,且无副作用。但有关临床报道很少。我们1997年～1998年以来应用灯盏花注射液治疗高粘滞血症患者,并与丹参注射液对照观察,临床疗效满意。现报告如下。 1 临床资料 1.1 一般资料:1997年6月～1998年6月,确诊为高粘滞血症患者共182例,均为住院病例,随机分为两组:治疗组101例,男61例,女40例,年龄
Erigeron Breviscapus Injection is a blood and phlegm type single-taste proprietary Chinese medicine intravenous injection that was upgraded in the 1990s. It has good pharmacological effects on the treatment of hyperviscosity and has no side effects. However, there are few clinical reports. Since 1997-1998, we have used Dengzhanhua injection to treat patients with hyperviscosity, and compared with Danshen injection, the clinical efficacy is satisfactory. The report is as follows. 1 Clinical data 1.1 General data: From June 1997 to June 1998, a total of 182 patients with hyperviscosity were diagnosed. All of them were hospitalized and were randomly divided into two groups: 101 patients in the treatment group, 61 males and females. 40 cases, age